Acta Scientific Medical Sciences (ASMS)(ISSN: 2582-0931)

Review Article Volume 6 Issue 1

CRISPER-CAS9 Utilization for HIV/AIDS Treatment

Chouia Yassine* and Amran Wafa

Department of Medicine, University of Amar Telidji, Algeria

*Corresponding Author: Chouia Yassine, Department of Medicine, University of Amar Telidji, Algeria.

Received: September 21, 2021; Published: December 09, 2021


Human immunodeficiency virus is (HIV) is a disease responsible for HIV/AIDS. The virus attacks immune cells of the host organism which renders them uncapable of assuring their role of defence, !thus leading to the deficiency of the immune system against other pathologies.

While HIV has gained the interest of a lot of scientists and doctors who trying to cure it, none of the treatments has been approved as having a substantial effect that eliminates the virus from the host’s body. The current medications only allow the immune system to recover partially while the virus could be under suppression. As technologies develop, new ways of treatment that are more effective and efficient than normal medications are starting to catch the attention of both scientists and doctors alike. One of these fast developing technologies is genetic modification technology, using CRISPR CAS9. This paper concerns itself with the possible applications of CRISPR CAS9 in the treatment of HIV/AIDS.


Keywords: Human Immunodeficiency Virus (HIV); CRISPR CAS9; Immune Cells; Immune System


  5. “How to Select the Best CRISPR Transfection Protocol”.
  7. Alexander G Allen., et al. “Gene Editing of HIV-1 Co-receptors to Prevent and/or Cure Virus Infection”. Frontiers in Microbiology 9 (2018): 2940.
  8. Yue Yang., et al. “CRISPR/Cas: Advances, Limitations, and Applications for Precision Cancer Research”. Frontiers in Medicine (Lausanne) 8 (2021): 649896.


Citation: Chouia Yassine and Amran Wafa. “CRISPER-CAS9 Utilization for HIV/AIDS Treatment". Acta Scientific Medical Sciences 6.1 (2022): 99-108.


Copyright: © 2022 Chouia Yassine and Amran Wafa. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.403

Indexed In

News and Events

Contact US